Table 2. Primary reason for discontinuation of efavirenza.
Cause | Number of cases (n = 99) |
Percentage |
---|---|---|
Central nervous system symptoms | 29 | 29.3 |
Rash | 23 | 23.2. |
Viral drug resistance mutations | 16 | 16.2 |
Non-adherence | 9 | 9.1 |
Gastrointestinal side effects | 6 | 6.1 |
Drug-drug interaction | 2 | 2.0 |
Hypercholesterolemia | 2 | 2.0 |
Other | 2 | 2.0 |
Unspecified | 10 | 10.1 |
Based on review of provider notes in the electronic medical record.